✦ LIBER ✦

Pharmacokinetics of ipriflavone, an isoflavone derivative, after intravenous and oral administration to rats: Hepatic and intestinal first-pass effects

✍ Scribed by So Hee Kim; Myung Gull Lee

Book ID: 117173364
Publisher: Elsevier Science
Year: 2002
Tongue: English
Weight: 204 KB
Volume: 70
Category: Article
ISSN: 0024-3205
DOI: 10.1016/s0024-3205(01)01508-9

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Pharmacokinetics and tissue distribution

Pharmacokinetics and tissue distribution of ipriflavone, an isoflavone derivative, after intravenous administration to rabbits

✍ So H. Kim; Jung S. Lee; Myung G. Lee 📂 Article 📅 2000 🏛 John Wiley and Sons 🌐 English ⚖ 173 KB 👁 1 views

Pharmacokinetic parameters of ipriflavone and its main metabolites, M1 and M5, after intravenous administration of spray-dried ipriflavone, SIP (10, 20, and 30 mg/kg as ipriflavone) and tissue distribution of ipriflavone, M1, and M5 after intravenous administration of SIP (20 mg/kg as ipriflavone) w

Pharmacokinetics of DA-8159, a new erect

Pharmacokinetics of DA-8159, a new erectogenic, after intravenous and oral administration to rats: Hepatic and intestinal first-pass effects

✍ Hyun J. Shim; Yu C. Kim; Kyung J. Park; Dong S. Kim; Jong W. Kwon; Won B. Kim; M 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 136 KB

The purposes of this study were to report dose-independent (after intravenous administration) and dose-dependent (after oral administration) area under the curve of plasma concentration versus time from time zero to time infinity (AUC), and gastric, intestinal, and/or hepatic first-pass effects (aft

Dose-independent pharmacokinetics of a n

Dose-independent pharmacokinetics of a new neuroprotective agent for ischemia-reperfusion damage, KR-31543, after intravenous and oral administration to rats: Hepatic and intestinal first-pass effects

✍ Mi H. Lee; Soo K. Bae; Eun J. Kim; Yoon G. Kim; Sun-O. Kim; Dong H. Lee; Hong Li 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 147 KB

The purpose of this study was to report dose-independent pharmacokinetics of KR-31543, a new neuroprotective agent for ischemia-reperfusion damage, after intravenous (iv) and oral (po) administration and first-pass effects after iv, intraportal, intragastric, and intraduodenal administration in rats

Dose-independent pharmacokinetics of a c

Dose-independent pharmacokinetics of a candidate for diabetic neuropathy, SR-4668, after intravenous and oral administration to rats: Intestinal first-pass effect

✍ Eun J. Kim; Soo K. Bae; Hee J. Kim; Yoon G. Kim; Sun-O. Kim; Dong H. Lee; Hong L 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 141 KB

Dose-independent pharmacokinetic parameters of SR-4668 were observed after intravenous (i.v.) administrations at doses of 25, 50, and 75 mg/kg and oral administrations at doses of 50, 100, and 150 mg/kg to rats. The hepatic, gastric, and intestinal first-pass effects of SR-4668 were also measured af

Pharmacokinetics of a new reversible pro

Pharmacokinetics of a new reversible proton pump inhibitor, YH1885, after intravenous and oral administrations to rats and dogs: hepatic first-pass effect in rats

✍ Kye S. Han; Yoon G. Kim; Joong K. Yoo; Jong W. Lee; Myung G. Lee 📂 Article 📅 1998 🏛 John Wiley and Sons 🌐 English ⚖ 175 KB 👁 1 views

The pharmacokinetics of YH1885 were evaluated after intravenous (iv) and oral administrations of the drug to rats and dogs. The reason for the low extent of bioavailability (F) of YH1885 after oral administration of the drug to rats and the absorption of the drug from various rat gastrointestinal (G

Dose-dependent pharmacokinetics of a new

Dose-dependent pharmacokinetics of a new reversible proton pump inhibitor, DBM-819, after intravenous and oral administration to rats: hepatic first-pass effect

✍ Eun J. Kim; Sun-O. Kim; Dong H. Lee; Hong Lim; Myung G. Lee 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 121 KB 👁 2 views